+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioanalytical Testing Market - Global Forecast 2026-2032- Product Image
Bioanalytical Testing Market - Global Forecast 2026-2032- Product Image
Sale

Bioanalytical Testing Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6143525
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioanalytical Testing Market is projected to reach USD 4.87 Billion in 2026. It is expected to continue growing at a CAGR of 7.10%, reaching USD 7.36 Billion by 2032.

Bioanalytical Testing: Executive Overview

Bioanalytical testing supports the quantitative measurement of drugs, metabolites, biomarkers, and other analytes in biological matrices. It is central to pharmacokinetic and pharmacodynamic assessment, bioequivalence studies, toxicology, clinical development, and therapeutic monitoring. The field depends on validated methods, controlled sample handling, fit-for-purpose instrumentation, and traceable data systems.

How Bioanalytical Testing Is Evolving

The landscape is shifting toward more sensitive, selective, and multiplexed analytical workflows. High-resolution mass spectrometry, ligand-binding assays, biomarker panels, and microsampling are expanding the types of biological questions laboratories can address. At the same time, regulators and sponsors are emphasizing method validation, reproducibility, data integrity, and documented control of preanalytical variables. Decentralized trials and specialty therapies are also increasing the need for flexible sample logistics and assays capable of working with limited-volume or complex specimens.

Artificial Intelligence’s Cumulative Impact on Testing

Artificial intelligence can improve bioanalytical testing by supporting chromatographic peak integration, anomaly detection, assay troubleshooting, sample prioritization, and review of large biomarker datasets. Its value depends on representative training data, validated performance, transparent audit trails, and human oversight. Laboratories should treat AI-enabled outputs as part of a controlled analytical process rather than as substitutes for scientific judgment. Governance should address model drift, cybersecurity, explainability, access controls, and compliance with applicable data and laboratory requirements.

Regional Insights Across the Global Landscape

North America benefits from mature pharmaceutical development ecosystems, advanced laboratory infrastructure, and strong demand for regulated analytical services. Europe combines established clinical research capabilities with coordinated regulatory expectations and growing interest in sustainable laboratory operations. Asia-Pacific is strengthening its role through expanding biopharmaceutical activity, clinical-trial capacity, and laboratory modernization, while differences in technical standards and workforce depth remain relevant. Latin America is developing bioanalytical capabilities alongside broader clinical research growth, with logistics, sample stability, and regulatory alignment requiring careful management. The Middle East is investing in healthcare and life-science infrastructure, creating opportunities for specialized testing partnerships. Africa shows emerging potential, particularly where laboratory networks, research institutions, and quality systems are being strengthened, although access to advanced platforms and specialized expertise remains uneven.

Group Insights: Trade and Regulatory Ecosystems

ASEAN countries are building regional life-science capacity, but laboratories must navigate differing regulatory processes, infrastructure levels, and cross-border sample requirements. BRICS economies provide substantial scientific and manufacturing capabilities, while national approaches to validation, data governance, and clinical research can vary. The European Union benefits from regulatory coordination and cross-border research networks, with data protection and quality expectations shaping operational design. G7 countries generally offer advanced analytical infrastructure, mature quality systems, and deep specialist talent pools. GCC states are developing healthcare and research ecosystems through investment in infrastructure and partnerships, while dependence on imported technologies and expertise can influence implementation. NATO members span diverse laboratory environments, yet interoperability, resilience, cybersecurity, and continuity planning are increasingly relevant to critical research operations.

Country Insights for Bioanalytical Testing

Australia combines strong clinical research institutions with advanced laboratory capabilities and geographically dispersed sample-management needs. Brazil and Mexico are expanding research and healthcare capacity, while regulatory coordination, logistics, and access to specialized platforms remain important considerations. Canada and the United States offer sophisticated pharmaceutical and contract-research ecosystems supported by extensive analytical expertise. China, India, Japan, and South Korea are strengthening biopharmaceutical development, instrumentation access, and translational research, although local compliance and operational requirements differ. France, Germany, Italy, Spain, and the United Kingdom benefit from established European research networks and rigorous quality expectations, with sustainability and data governance becoming increasingly prominent. Russia maintains scientific and laboratory capabilities, but organizations operating across borders must carefully assess applicable regulatory, supply-chain, and collaboration constraints.

Practical Priorities for Industry Leaders

Leaders should align assay strategy with the intended clinical or regulatory decision, using fit-for-purpose validation rather than applying identical requirements to every program. Investments should prioritize robust sample logistics, reference standards, instrument maintenance, electronic data integrity, and documented change control. Laboratories can improve resilience by qualifying alternative suppliers, strengthening staff training, and designing continuity plans for equipment, reagents, and critical data systems. AI adoption should begin with bounded, measurable use cases and proceed through validation, monitoring, and periodic requalification. Cross-functional governance involving analytical scientists, quality teams, biostatisticians, regulatory specialists, and cybersecurity professionals can help ensure that innovation remains scientifically defensible and inspection-ready.

Research Methodology for the Executive Summary

This executive summary applies a structured qualitative assessment of bioanalytical testing, organized around technological change, regulatory expectations, laboratory operations, artificial intelligence, and geographic conditions. Regional, group, and country discussions synthesize established characteristics of research infrastructure, biopharmaceutical activity, healthcare systems, quality requirements, and operational environments. Claims are intentionally limited to directional, evidence-grounded observations. No market estimates, market shares, forecasts, or company-specific evaluations are included; conclusions should be supplemented with current regulatory documents, peer-reviewed evidence, and local feasibility assessments before investment or compliance decisions.

Conclusion: Building Reliable, Adaptive Bioanalytical Operations

Bioanalytical testing is becoming more integrated, data-intensive, and sensitive to operational quality. Success will depend on combining advanced analytical platforms with disciplined validation, dependable sample management, skilled personnel, and secure digital infrastructure. Regional and national differences make adaptable operating models essential, while responsible AI governance can improve efficiency without weakening scientific accountability. Organizations that connect innovation with reproducibility, regulatory readiness, and resilience will be better positioned to support complex development programs.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of artificial intelligence and machine learning algorithms in LC-MS data processing for rapid biomarker identification and quantification
5.2. Growing adoption of high-throughput automated sample preparation systems to enhance assay reproducibility and throughput in bioanalytical laboratories
5.3. Rising demand for ligand-binding and hybrid immunoassay techniques to support quantification of large molecule biotherapeutics in complex biological matrices
5.4. Emergence of dried blood spot and volumetric absorptive microsampling methods for decentralized clinical trial sample collection and remote patient monitoring
5.5. Expansion of microflow and nano-flow liquid chromatography coupled with high-resolution mass spectrometry for ultratrace analysis and solvent reduction
5.6. Increasing regulatory focus on harmonization of bioanalytical method validation standards and data integrity compliance across global markets
5.7. Integration of multiplexed bead-based immunoassays and proximity extension assays for high-dimensional cytokine and protein biomarker profiling
5.8. Application of digital PCR and droplet digital PCR technologies for precise quantification of low abundance nucleic acid biomarkers in gene therapy studies
5.9. Adoption of cell-based potency assays for functional evaluation of biosimilars and novel gene editing therapeutics in bioanalysis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioanalytical Testing Market, by Product Type
8.1. Introduction
8.2. Consumables
8.3. Instruments
8.3.1. Chromatography Instruments
8.3.1.1. Gas Chromatography
8.3.1.2. Liquid Chromatography
8.3.2. Immunoassay Instruments
8.3.3. Mass Spectrometry Instruments
8.3.4. Spectroscopy Instruments
8.4. Services
8.5. Software
9. Bioanalytical Testing Market, by Technique
9.1. Introduction
9.2. Chromatography
9.2.1. Gas Chromatography
9.2.2. Liquid Chromatography
9.2.2.1. High Performance Liquid Chromatography
9.2.2.2. Ultra Performance Liquid Chromatography
9.3. Immunoassay
9.4. Mass Spectrometry
9.4.1. GC-MS
9.4.2. LC-MS/MS
9.4.3. MALDI-TOF
9.5. Spectroscopy
10. Bioanalytical Testing Market, by Application
10.1. Introduction
10.2. Academic Research
10.3. Clinical Diagnostics
10.3.1. Biomarker Analysis
10.3.2. Therapeutic Drug Monitoring
10.4. Environmental
10.5. Food & Beverage
10.5.1. Nutritional Analysis
10.5.2. Pesticide Residue Analysis
10.6. Pharmaceutical
10.6.1. Bioanalysis
10.6.2. Drug Discovery
10.6.3. Quality Control
11. Bioanalytical Testing Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.2.1. Research Institutes
11.2.2. Universities
11.3. Contract Research Organizations
11.3.1. Clinical Services
11.3.2. Preclinical Services
11.4. Hospitals & Clinics
11.4.1. Private Clinics
11.4.2. Public Hospitals
11.5. Pharmaceutical & Biotechnology Companies
11.5.1. Big Pharma
11.5.2. Emerging Biotech
12. Bioanalytical Testing Market, by Detection Mode
12.1. Introduction
12.2. Fluorescence Detection
12.2.1. Steady State
12.2.2. Time Resolved
12.3. Mass Spectrometric Detection
12.3.1. GC-MS
12.3.2. LC-MS/MS
12.3.3. MALDI-TOF
12.4. UV-Vis Detection
12.4.1. Double Beam
12.4.2. Single Beam
13. Americas Bioanalytical Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Bioanalytical Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Bioanalytical Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. IQVIA Inc.
16.3.2. Laboratory Corporation of America Holdings
16.3.3. Charles River Laboratories International, Inc.
16.3.4. Pharmaceutical Product Development, LLC
16.3.5. ICON plc
16.3.6. Parexel International Corporation
16.3.7. Eurofins Scientific SE
16.3.8. SGS SA
16.3.9. Thermo Fisher Scientific Inc.
16.3.10. WuXi AppTec Co., Ltd.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. BIOANALYTICAL TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOANALYTICAL TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOANALYTICAL TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BIOANALYTICAL TESTING MARKET: RESEARCHAI
FIGURE 26. BIOANALYTICAL TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. BIOANALYTICAL TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. BIOANALYTICAL TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOANALYTICAL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY IMMUNOASSAY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY IMMUNOASSAY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SPECTROSCOPY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY NUTRITIONAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PESTICIDE RESIDUE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIOANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIOANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY BIG PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY EMERGING BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY EMERGING BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY STEADY STATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY STEADY STATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TIME RESOLVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY TIME RESOLVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MALDI-TOF, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MALDI-TOF, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DOUBLE BEAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY DOUBLE BEAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SINGLE BEAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY SINGLE BEAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS BIOANALYTICAL TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES BIOANALYTICAL TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 243. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 246. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 247. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 248. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 249. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 250. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 251. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 252. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 253. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 254. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 255. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 256. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 257. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 260. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 261. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2018-2024 (USD MILLION)
TABLE 262. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2025-2030 (USD MILLION)
TABLE 263. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 264. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 265. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 268. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 269. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 272. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 273. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 274. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 275. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2018-2024 (USD MILLION)
TABLE 276. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY DETECTION MODE, 2025-2030 (USD MILLION)
TABLE 277. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2018-2024 (USD MILLION)
TABLE 278. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY FLUORESCENCE DETECTION, 2025-2030 (USD MILLION)
TABLE 279. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2018-2024 (USD MILLION)
TABLE 280. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRIC DETECTION, 2025-2030 (USD MILLION)
TABLE 281. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2018-2024 (USD MILLION)
TABLE 282. CANADA BIOANALYTICAL TESTING MARKET SIZE, BY UV-VIS DETECTION, 2025-2030 (USD MILLION)
TABLE 283. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 286. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 287. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 288. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 289. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 292. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 293. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 294. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 295. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
TABLE 296. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
TABLE 297. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2018-2024 (USD MILLION)
TABLE 302. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY FOOD & BEVERAGE, 2025-2030 (USD MILLION)
TABLE 303. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 304. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 305. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
TABLE 308. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
TABLE 309. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 310. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 311. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 312. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 313. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 314. MEXICO BIOANALYTICAL TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION

Companies Mentioned

  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • ICON plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Parexel International Corporation
  • Pharmaceutical Product Development, LLC
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Bioanalytical Testing Services Market Report Size, Share, Trends and Forecast by Molecule Type, Test Type, Workflow, and Region, 2026-2034 - Product Image

Bioanalytical Testing Services Market Report Size, Share, Trends and Forecast by Molecule Type, Test Type, Workflow, and Region, 2026-2034

  • Report
  • 143 Pages
  • Global
From
Large Molecule Bioanalytical Technologies Market Report 2026 - Product Image

Large Molecule Bioanalytical Technologies Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bioanalytical Testing Services Market - Global Forecast 2026-2032 - Product Image

Bioanalytical Testing Services Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Bioanalytical Testing Services - Global Strategic Business Report - Product Image

Bioanalytical Testing Services - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From
Large Molecule Bioanalytical Technologies - Global Strategic Business Report - Product Image

Large Molecule Bioanalytical Technologies - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.